LWAC
DGX icon

Laurel Wealth Advisors (California)’s Quest Diagnostics DGX Stock Holding History

Laurel Wealth Advisors (California)’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$1.54M Sell
9,827
-380
-4% -$54.6K 0.15% 152
2022
Q3 		$1.25M Sell
10,207
-240
-2% -$31.6K 0.13% 166
2022
Q2 		$1.39M Sell
10,447
-400
-4% -$54.5K 0.14% 156
2022
Q1 		$1.49M Buy
10,847
+786
+8% +$110K 0.12% 179
2021
Q4 		$1.74M Sell
10,061
-330
-3% -$50.2K 0.13% 152
2021
Q3 		$1.51M Buy
10,391
+21
+0.2% +$3.07K 0.28% 77
2021
Q2 		$1.37M Sell
10,370
-100
-1% -$13.1K 0.18% 130
2021
Q1 		$1.34M Sell
10,470
-300
-3% -$37K 0.2% 113
2020
Q4 		$1.28M Sell
10,770
-12
-0.1% -$1.46K 0.19% 125
2020
Q3 		$1.23M Buy
10,782
+758
+8% +$89.6K 0.2% 119
2020
Q2 		$1.14M Sell
10,024
-47
-0.5% -$4.99K 0.21% 119
2020
Q1 		$809K Buy
+10,071
New +$1.04M 0.19% 134

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Laurel Wealth Advisors (California)'s DGX Position: Q4 2022 in Review

Laurel Wealth Advisors (California) reduced its Quest Diagnostics (DGX) stake by 3.7% in Q4 2022, selling an estimated $54.6K and leaving 9,827 shares worth $1.54M. The position accounts for 0.15% of the portfolio, ranked #152.

Laurel Wealth Advisors (California) first reported a position in DGX in Q1 2020 and has held it in 12 quarters since. The position peaked at $1.74M in Q4 2021. 879 funds tracked by Wall St. Rank hold DGX as of Q4 2022.

  • Laurel Wealth Advisors (California) held 9,827 shares of Quest Diagnostics worth $1.54M as of Q4 2022.
  • Laurel Wealth Advisors (California) sold 380 Quest Diagnostics shares in Q4 2022, an estimated $54.6K.
  • Quest Diagnostics made up 0.15% of Laurel Wealth Advisors (California)'s portfolio in Q4 2022, its #152 holding.
  • Laurel Wealth Advisors (California) first reported a position in Quest Diagnostics in Q1 2020 and has held it in 12 quarters since.
  • Laurel Wealth Advisors (California)'s Quest Diagnostics position peaked at $1.74M in Q4 2021.
  • 879 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2022.

Based on Laurel Wealth Advisors (California)'s 13F filing for Q4 2022, filed 14 Feb 2023.